Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tango Therapeutics granted 170,000 stock options and 40,000 RSUs to a new employee under its 2023 Inducement Plan. The grants were made pursuant to Nasdaq Listing Rule 5635(c)(4), which allows equity awards as an inducement to enter employment.
Key figures
- Offering Price
- 23.1
- Rsus granted
- 40000
- Options granted
- 170000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.